Catherine is an experienced drug development consultant. She previously spent nearly 25 years in the pharmaceutical industry (Allergan, Eisai, Schwartz Pharma) where her roles have included being responsible for global drug development programs. Catherine has a proven track record of hands-on operational and strategic experience which has led to many successful drug approvals, including for rare diseases. She has also authored more than 20 publications in peer-reviewed scientific/medical journals.
Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.